Skip to Main Content
Wexler Boley & Elgersma LLP
  • Our Firm
    • Who We Serve
      • Shareholders
      • Whistleblowers
      • Consumers
      • Businesses
      • Government Entities
    • Our Professionals
    • Working with Wexler Boley & Elgersma LLP
    • Locations
    • News
    • Careers
    • Report Your Concern
    • Testimonials
  • Practice Areas
    • Antitrust Litigation
    • Business & Commercial Litigation
    • Securities & Corporate Governance
    • Healthcare Litigation
    • Consumer Protection
    • Whistle Blower False Claims Litigation
    • Government Representation
    • Employment Litigation
  • Cases
    • Antitrust Litigation Cases
    • Business & Commercial Litigation Cases
    • Consumer Protection Cases
    • Employment Litigation Cases
    • Government Representation Cases
    • Healthcare Litigation Cases
    • Mass Tort Litigation Cases
    • Securities & Corporate Governance Cases
    • Whistle Blower False Claims Cases
  • Investigations
    • Similac Toxic Infant Formula Lawsuit
    • Kid’s Castle Biometric Privacy Lawsuit
    • Contaminated Baby Food Lawsuit
    • Fatal Sportmix Pet Food Recall Class Action Lawsuit
    • Claire’s Data Breach Lawsuit
    • Insurance Denial for Mental Health and Substance Abuse Treatment
    • Perpetual Sales Litigation
    • Railroad Price-Fixing Lawsuit
    • Medicare Advantage Fraud Litigation
    • Biometric Fingerprinting Litigation
  • Blog
  • Contact Us
See all blog posts
6.27.2018

Connecticut Medicaid No Longer Covering Essure Birth Control

By Brian Lynch
In The News, You Should Know

Over the past few years, Bayer has been pulling their Essure permanent birth control devices off the market in countries around the world, citing changes in patient demand. But despite thousands of patient complaints, innumerable lawsuits, and increased federal restrictions on the device, U.S. Essure sales have continued unabated until now. The global revolt against Essure permanent birth control will reach U.S. shores this July, at least in Connecticut, as the state’s Department of Social Services has announced that Medicaid will no longer cover the cost of implanting Essure.

Connecticut’s decision to suspend coverage of the sterilization device follows closely on the heels of the FDA’s added restrictions on Essure. Citing the recently imposed action as a direct result of the policy change, Connecticut’s DSS will suspend Medicaid coverage of Essure implantation effective July 1, 2018.

“Effective for dates of service July 1, 2018 and forward, the permanent implantable contraceptive intratubal occlusion device and delivery system that is used as part of bilateral fallopian tube cannulation to induce occlusion by placement of permanent implants procedure will no longer be covered under the Healthcare Common Procedure Coding System (HCPCS) code A4264-Intratubal occlusion device. Other birth control devices such as the Falope ring and filshie clips remain covered and should continue to be billed under HCPCS code A4264.

Additionally, Current Procedure Terminology (CPT) code 58565-Hysteroscopy sterilization will be enddated for dates of service, July 1, 2018 and forward on the following fee schedules: physician-surgical, ambulatory surgical centers, and family planning clinics. The CPT code will be changed to a “no” under the payment type column on the Connecticut Medical Assistance Program Addendum B for outpatient hospitals.”

Though not directly named in the policy update, Essure is currently the only permanent tubal occlusion device on the market.

This change in policy is being seen by many anti-Essure advocates as a major step in eliminating the device in the U.S. When the Essure was first banned in Brazil in the spring of 2017, many countries began to follow suit. Currently, Bayer has ceased all sales of Essure outside of the United States.

Share

No Comments

Leave a Reply Cancel reply

Receive News Updates

Get the latest from Wexler Wallace LLP & stay informed.

Categories

  • Media Appearances
  • Uncategorized
  • Columns
    • Guest Post
    • Ken Wexler
    • Ed Wallace
  • Practice Areas
    • Consumer Protection
    • Mass Tort Litigation
    • Business & Commercial Litigation
    • Healthcare Litigation
    • Employment Litigation
  • Cases
  • Hall Of Shame
    • Villain Of The Week
  • In The News
    • Public Victories
  • Featured Investigations
  • The Firm
    • News releases
    • Around The World
    • Our Professionals
    • Chicago
  • You Should Know
    • For Investors
    • For Businesses
    • For Consumers
  • Featured Cases
  • awards
  • Facebook
  • Twitter
  • LinkedIn
Image

311 S. Wacker Drive,
Suite 5450
Chicago, IL 60606
P_312.346.2222
F_312.346.0022

  • Our Firm
  • Practice Areas
  • Cases
  • Investigations
  • Newsroom
  • Blog
  • Contact Us
  • Sitemap
  • Privacy Statement
  • Legal Disclaimer

2022 © Wexler Boley & Elgersma LLP